Biocept Inc (OTCPK:BIOCQ)
$ 0.0002 0 (0%) Market Cap: 1,000.00 Enterprise Value: 4.96 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2019 Biocept Inc Earnings Call Transcript

Mar 25, 2020 / 08:30PM GMT
Release Date Price: $105 (+12.43%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Biocept 2019 fourth-quarter and full-year financial results conference call. (Operator Instructions) As a reminder, this conference call is being recorded today, March 25, 2020.

I'd now like to turn the call over to Jody Cain. Please go ahead, ma'am.

Jody Cain
LHA - IR

This is Jody Cain at LHA. Thank you for participating in today's conference call. Joining me from Biocept are Michael Nall, President and Chief Executive Officer; and Tim Kennedy, Senior Vice President of Operations and Chief Financial Officer.

During this call, management will be making a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical fact and generally can be identified by terms such as anticipate, estimate, believes, could, expect, intend, may, plan, potential, predict, project, should, will, would or the negative of those terms.

Forward-looking statements involve

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot